» Articles » PMID: 37629105

Perspectives of Proteomics in Respiratory Allergic Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 26
PMID 37629105
Authors
Affiliations
Soon will be listed here.
Abstract

Proteomics in respiratory allergic diseases has such a battery of techniques and programs that one would almost think there is nothing impossible to find, invent or mold. All the resources that we document here are involved in solving problems in allergic diseases, both diagnostic and prognostic treatment, and immunotherapy development. The main perspectives, according to this version, are in three strands and/or a lockout immunological system: (1) Blocking the diapedesis of the cells involved, (2) Modifications and blocking of paratopes and epitopes being understood by modifications to antibodies, antagonisms, or blocking them, and (3) Blocking FcεRI high-affinity receptors to prevent specific IgEs from sticking to mast cells and basophils. These tools and targets in the allergic landscape are, in our view, the prospects in the field. However, there are still many allergens to identify, including some homologies between allergens and cross-reactions, through the identification of structures and epitopes. The current vision of using proteomics for this purpose remains a constant; this is also true for the basis of diagnostic and controlled systems for immunotherapy. Ours is an open proposal to use this vision for treatment.

References
1.
Demoly P . [Respiratory allergic disease genes]. Rev Pneumol Clin. 2003; 59(2 Pt 1):67-75. View

2.
Komatsu N, Mariotti-Ferrandiz M, Wang Y, Malissen B, Waldmann H, Hori S . Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A. 2009; 106(6):1903-8. PMC: 2644136. DOI: 10.1073/pnas.0811556106. View

3.
Bertoline L, Lima A, Krieger J, Teixeira S . Before and after AlphaFold2: An overview of protein structure prediction. Front Bioinform. 2023; 3:1120370. PMC: 10011655. DOI: 10.3389/fbinf.2023.1120370. View

4.
Karamloo F, Schmitz N, Scheurer S, Foetisch K, Hoffmann A, Haustein D . Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins. J Allergy Clin Immunol. 1999; 104(5):991-9. DOI: 10.1016/s0091-6749(99)70080-1. View

5.
Porebski G, Piotrowicz-Wojcik K, Spiewak R . ELISpot assay as a diagnostic tool in drug hypersensitivity reactions. J Immunol Methods. 2021; 495:113062. DOI: 10.1016/j.jim.2021.113062. View